These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 15234143)

  • 1. Neodymium:yttrium-aluminum-garnet capsulotomy and intraocular pressure in pseudophakic patients with glaucoma.
    Barnes EA; Murdoch IE; Subramaniam S; Cahill A; Kehoe B; Behrend M
    Ophthalmology; 2004 Jul; 111(7):1393-7. PubMed ID: 15234143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intraocular pressure after ND: YAG laser capsulotomy in pseudophakic patients with glaucoma].
    Sesar A; Petric I; Sesar I; Lacmnovic-Loncar V; Jurisić D; Tomić Z; Mandić Z
    Acta Med Croatica; 2006; 60(2):109-12. PubMed ID: 16848199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy.
    Unal M; Yücel I; Akar Y
    J Cataract Refract Surg; 2006 Sep; 32(9):1499-502. PubMed ID: 16931262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery.
    Chen TC
    J Cataract Refract Surg; 2005 Sep; 31(9):1707-12. PubMed ID: 16246772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of apraclonidine in preventing the rise in intraocular pressure after neodymium:YAG posterior capsulotomy.
    Pollack IP; Brown RH; Crandall AS; Robin AL; Stewart RH; White GL
    Trans Am Ophthalmol Soc; 1988; 86():461-72. PubMed ID: 2979050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of apraclonidine on the intraocular pressure of glaucoma patients following Nd:YAG laser posterior capsulotomy.
    Cullom RD; Schwartz LW
    Ophthalmic Surg; 1993 Sep; 24(9):623-6. PubMed ID: 7901828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures.
    Chevrier RL; Assalian A; Duperré J; Lesk MR
    Ophthalmic Surg Lasers; 1999 Mar; 30(3):199-204. PubMed ID: 10100253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical 2.0% dorzolamide vs oral acetazolamide for prevention of intraocular pressure rise after neodymium:YAG laser posterior capsulotomy.
    Ladas ID; Baltatzis S; Panagiotidis D; Zafirakis P; Kokolakis SN; Theodossiadis GP
    Arch Ophthalmol; 1997 Oct; 115(10):1241-4. PubMed ID: 9338667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of apraclonidine to prevent delayed IOP elevation after Nd:YAG laser posterior capsulotomy.
    Nesher R; Kolker AE
    Trans Am Ophthalmol Soc; 1990; 88():229-32; discussion 233-6. PubMed ID: 1982748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of 0.25% apraclonidine in preventing intraocular pressure elevation after Nd:YAG laser posterior capsulotomy.
    Simsek S; Ertürk H; Demirok A; Cinal A; Yasar T; Karadenizli C
    Eur J Ophthalmol; 1998; 8(3):167-72. PubMed ID: 9793771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of apraclonidine to reduce acute intraocular pressure rise following Q-switched Nd:YAG laser iridotomy.
    Kitazawa Y; Taniguchi T; Sugiyama K
    Ophthalmic Surg; 1989 Jan; 20(1):49-52. PubMed ID: 2648232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 0.2% brimonidine in preventing intraocular pressure elevation after Nd:YAG laser posterior capsulotomy.
    Seong GJ; Lee YG; Lee JH; Lim SJ; Lee SC; Hong YJ; Kwon OW; Kim HB
    Ophthalmic Surg Lasers; 2000; 31(4):308-14. PubMed ID: 10928668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apraclonidine and anterior segment laser surgery. Comparison of 0.5% versus 1.0% apraclonidine for prevention of postoperative intraocular pressure rise.
    Rosenberg LF; Krupin T; Ruderman J; McDaniel DL; Siegfried C; Karalekas DP; Grewal RK; Gieser DK; Williams R
    Ophthalmology; 1995 Sep; 102(9):1312-8. PubMed ID: 9097768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of acetazolamide and apraclonidine in the control of intraocular pressure following phacoemulsification.
    Scuderi G; Regine F; Perdicchi A; Mannino G; Recupero SM
    Ophthalmologica; 2006; 220(6):356-60. PubMed ID: 17095879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and tolerability of apraclonidine (ALO 2145, 1%) in the prevention of early ocular hypertonia, after trabeculoretraction using argon laser and posterior capsulotomy using Nd:YAG laser].
    Raspiller A; Berrod JP
    J Fr Ophtalmol; 1992; 15(12):651-6. PubMed ID: 1363731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraocular pressure control after Nd:YAG laser posterior capsulotomy in eyes with glaucoma.
    Lin JC; Katz LJ; Spaeth GL; Klancnik JM
    Br J Ophthalmol; 2008 Mar; 92(3):337-9. PubMed ID: 18211944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of intraocular pressure elevations after argon laser trabeculoplasty: comparison of brimonidine 0.2% to apraclonidine 1.0%.
    Barnes SD; Campagna JA; Dirks MS; Doe EA
    Ophthalmology; 1999 Oct; 106(10):2033-7. PubMed ID: 10519604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of topical brimonidine to prevent intraocular pressure elevations following Nd:YAG-laser posterior capsulotomy.
    Gartaganis SP; Mela EK; Katsimpris JM; Petropoulos JK; Karamanos NK; Koliopoulos JX
    Ophthalmic Surg Lasers; 1999; 30(8):647-52. PubMed ID: 10507567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rarity of clinically significant rise in intraocular pressure after laser peripheral iridotomy with apraclonidine.
    Lewis R; Perkins TW; Gangnon R; Kaufman PL; Heatley GA
    Ophthalmology; 1998 Dec; 105(12):2256-9. PubMed ID: 9855156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of anterior capsule polishing on posterior capsule opacification and neodymium:YAG capsulotomy rates: three-year randomized trial.
    Menapace R; Wirtitsch M; Findl O; Buehl W; Kriechbaum K; Sacu S
    J Cataract Refract Surg; 2005 Nov; 31(11):2067-75. PubMed ID: 16412917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.